J. J. Finkelstein, CEO RegeneRx, “Focused on Developing Therapeutic Peptide for Tissue & Organ Protection, Repair and Regeneration” at the BioMaryland Booth at BIO International Convention 2012

On September 13, 2012 By

Micro-Cap Review Magazine Publishes Spring/Summer Issue

On August 29, 2012 By

Dr. Jun Hayashi, Vice President of Precision Antibody, “Customized Antibodies for Pharmaceutical/Biotech Companies, Academic, Government & Non-Profit Research Institutions” at the BioMaryland Booth at BIO International Convention 2012

On August 28, 2012 By

Dr. Ginette Serrero, Co-Founder & CEO A&G Pharmaceutical, Inc. “Developing Therapeutic & Diagnostic for Breast and Lung Cancers” at the BioMaryland Booth at BIO International Convention 2012

On August 28, 2012 By

Dr. Irene Gonzalez, CEO Valens Therapeutics, Inc. “Focused on Developing Therapeutic for Pancreatic Cancer” at the BioMaryland Booth at BIO International Convention

On August 23, 2012 By

Dr. Thomas Hyde, COO Lieber Institute for Brain Development, “Research Institute Exclusively Focused on Schizophrenia & Related Psychiatric Disorders” at the Science and Technology Park at Johns Hopkins University

On August 22, 2012 By

Tony Talalay, CEO Brassica Protection Products LLC, “Broccoli? Maybe Our Mother’s Were Right?” at the Science and Technology Park at Johns Hopkins University

On August 22, 2012 By

Dr. Ken Malone, CEO Ablitech, Inc. “We Protect Silencing RNA & Get it Inside Cancer Cells” at the BioMaryland Booth at BIO International Convention 2012

On August 20, 2012 By

Jane Shaab, Executive Director of University of Maryland BioPark, “University-Associated Research Park Accelerating Biotech Commercialization & Economic Development” at the BioMaryland Booth in BIO International Convention 2012

On August 20, 2012 By

Tom Sadowski, President & CEO Economic Alliance of Greater Baltimore, “Fostering Development Through Partnership & Thought Leadership” at the BioMaryland Booth at BIO International Convention 2012

On August 17, 2012 By